66
Views
38
CrossRef citations to date
0
Altmetric
Research Article

Risk Factors for HIV-2 Seropositivity Among Older People in Guinea-Bissau. A Search for the Early History of HIV-2 Infection

Pages 169-175 | Published online: 08 Jul 2009

  • Poulsen AG, Kvinesdal B, Aaby P et al. Prevalence of and mortality from Human Immunodeficiency Virus Type 2 in Bissau, West Africa. Lancet 1989; i: 827–31.
  • Wilkins A, Ricard D, Todd J, et al. The epidemiology of HIV infection in a rural area of Guinea-Bissau. AIDS 1993; 7: 1119–22.
  • Markovitz DM. Infection with Human Immunodeficiency Virus Type 2. Ann Intern Med 1993; 118: 211–8.
  • Clavel F, Mansinho K, Chamaret S, et al. Human Immunodeficiency Virus type 2 infection associated with AIDS in West Africa. N Engl J Med 1987; 316: 1180–5.
  • Kanki PJ, Travers KU, M’Boup S, et al. Slower heterosexual spread of HIV-2 than HIV-1. Lancet 1994; 343: 943–6.
  • Poulsen AG, Kvinesdal B, Aaby P, et al. Lack of evidence of vertical transmission of human immunodeficiency virus type 2. J AIDS 1992; 5: 2530.
  • Barin F, M’Boup S, Denis F, et al. Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents in West Africa. Lancet 1985; 2: 1387–9.
  • Poulsen AG, Aaby P, Gottschau A, et al. HIV-2 infection in Bissau, West Africa, 1987–1989: incidence, prevalences and routes of transmission. J Acquir Immune Defic Syndr 1993; 6: 941–8.
  • Kestens L, Brattegaard K, Adjorlolo G, et al. Immunological comparison of HIV-1-, HIV-2- and dually-reactive women delivering in Abidjan, Côte d’Ivoire. AIDS 1992; 6: 803–7.
  • Kanki P, M’Boup S, Marlink R, et al. Prevalence and risk determinants of Human Immunodeficiency Virus Type 2 (HIV-2) and Human Immunodeficiency Virus Type 1 (HIV-1) in West African Female Prostitutes. Am J Epidemiol 1992; 136: 895–907.
  • Le Guenno B, Pison G, Enel C. HIV-2 prevalence in three rural regions of Senegal: low levels and heterogeneous distributions. Trans Royal Soc Trop Med Hyg 1992; 86: 301–2.
  • Wilkins A, Hayes R, Alonso P, et al. Risk factors for HIV-2 infection in Gambia. AIDS 1991; 5: 1127–32.
  • Harrison LH, da Silva AP, Gayle HD, et al. Risk factors for HIV-2 infection in Guinea-Bissau. J Acquir Immune Defic Syndr 1991; 4: 1155–60.
  • Nauclér A, Andreasson PA, Costa CM et al. HIV-2 associated AIDS and HIV-2 seroprevalence in Bissau, Guinea-Bissau. J Acquir Immune Defic Syndr 1989; 2: 88–93.
  • Poulsen AG, Aaby P, Jensen H, et al. Nine years HIV-2 associated mortality in a community study from Guinea-Bissau. Lancet 1997; 349: 911–4.
  • Ricard D, Wilkins A, N’Gum PT, et al. The effects of HIV-2 infection in a rural area of Guinea-Bissau. AIDS 1994; 8: 977–82.
  • Ancell R, Bletry O, Baglin AC, et al. Long incubation period for HIV-2 infection [Letter]. Lancet 1987; i: 688–9.
  • Saal F, Sidibe S, Alves-Cardoso E, et al. Anti HIV-2 serological screening in Portuguese populations native from or having had close contact with Africa. AIDS Res Hum Retroviruses 1987; 3: 341–2.
  • Buckner M. Village women and town prostitutes: cultural factors relevant to prostitution and HIV epidemiology in Guinea-Bissau. In: Becker C, Dozon JP, Obbo C, Touré M, editors. Vivre et penser la sida en Afrique. Paris: editions Karthala, 1999: 389–404.
  • Høgsborg M, Aaby P. Sexual relations, use of condoms and perceptions of AIDS in an urban area of Guinea-Bissau with a high prevalence of HIV2. In: Dyson T, editor. Sexual behaviour and networking: anthropological and socio-cultural studies on the transmission of HIV. Liege: Ordina; 1992. p. 203–32.
  • Nauclér A, Albino P, da Silva AP, et al. Sexually transmitted diseases and HIV-2 associated AIDS and HIV-2 seroprevalence in Bissau, Guinea-Bissau.
  • Norrgren H, Silvia M, Leithner T, et al. Comparison of CD4 counts, viral load and genetic variation in HIV-2 infection: AIDS cases, old non-progressors and young asymptomatic subjects in Bissau, Guinea-Bissau. J AIDS. In press.
  • Xiang Z, Ariyoshi K, Wilkins A, et al. HIV Type 2 pathogenicity is not related to subtype in rural Guinea Bissau. AIDS Res Hum Retrovir 1997; 13: 501–3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.